Immunology

New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.

Unlike other cells in the body that mount a strong immune response against microbial invaders, skin cells use an epigenetic mechanism to ignore most of the microbes they see. These findings reveal a potential new drug target for inflammatory skin diseases.

Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.

A new antibody treatment reduced levels of type I interferon-producing cells in patients with cutaneous lupus, improving skin symptoms during phase 1 clinical trials.

Promising results from clinical trials show that allergen tolerization works for many patients.

NASA flight surgeon Richard Scheuring monitors astronauts’ health before, during, and after their journeys into space. What he and others learn about space’s impact on health will help scientists develop novel treatments for people on Earth.

From microgravity to radiation, space wreaks havoc on astronauts’ immune systems, potentially putting them at risk of infection from microbes onboard.

Discover leading immunotherapy targets in the the drug development pipeline.

Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.